Search

everythinglearnresearchcommunity

for

Search:↓

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rate.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Interferon therapy improves quality of life for chronic hepatitis B patients.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

A new delivery system makes Curcumin more effective and safer against viruses.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Tangent screens help detect visual field defects from vigabatrin.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Various medications and vaccines can cause serious side effects.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

The patient improved after antiviral treatment for a viral infection.

Provenge extends prostate cancer survival by about 4 months.